The first testing of the drug was carried out on mice that had been artificially vaccinated with melanoma. After that, some rodents were given the vaccine, while others were not. On the 15th day, when the animals' immune system began to work, scientists saw a large difference in tumor size between vaccinated and unvaccinated mice. Those rodents that received the vaccine are alive. In the unvaccinated, a fatal outcome was recorded between the 19th and 22nd day. Ginzburg added that the experiment is currently ongoing, writes lenta.ru.
"Indeed, a universal technology has been created that allows us to solve literally all the problems of oncology. It's another matter how this will be implemented in practice," he said.
The scientist noted that the therapeutic vaccine was created on the basis of mRNA technologies, similar to drugs from COVID-19. It will be administered to people who have already contracted cancer. It is noteworthy that the vaccines will be individual, that is, developed taking into account the specific characteristics of the patient.
